Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.
Advertisement
The Scientist
Most Recent
The scientific community and the impact of the Myriad Genetics Supreme Court decision
The cell fragments play a role in the body’s first line of defense against bacterial infection, helping white blood cells grab blood-borne bacteria in the liver.
Supreme Court says no patenting (natural) genes; brain-computer interfaces mimic motor learning in brain; regenerating finger tips; gene therapy goes deeper; NIH needs more diversity; cross-border collaboration
The Justices have decided that isolated sequences of human DNA are not eligible for patent protection, but rules that artificial sequences can be patented.
Directed evolution of a gene therapy virus vector improves its penetration into the retina.
Researchers identify the signaling program that enables finger and toenail stem cells to direct digit regeneration after amputation.
A Canadian lab demonstrates upgrades to hospital cyclotrons that can yield enough diagnostic tracer element overnight to meet an entire city’s daily needs.
US universities need to reach across their own borders to retain global scientific preeminence.
The NIH remains a Caucasian-dominated workforce. Why haven’t the agency’s efforts to diversify been successful?
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
